Articles

TechPoint to focus on IT firms specializing in medical, life sciences sectors

Long tracking the emergence of information technology firms involved in the health and life sciences sector, the state’s
IT trade group, TechPoint, is undergoing a mitosis of sorts to help fuel the trend. It has created Advancing
Life Science & Health Care Information Technology, or ALHIT, which will focus on growing this subset of the IT realm.

Read More

Doctors balk at Senate attempt to cut waste

Some Indianapolis-area doctors fear a bill in the U.S. Senate would botch the way costs for tests and procedures are calculated, and ultimately
lead to a reimbursement system that works worse than the existing system.

Read More

KATTERJOHN: Get out and vote for Wishard

You know, there’s an election on Nov. 3, right? We’re not voting for president, governor,
mayor, or even dog catcher. We’re voting for a critical piece of the health care delivery system in central Indiana: whether to allow Marion County
Health & Hospital Corp. to sell bonds to build a new Wishard Hospital.

Read More

Eli Lilly CEO banking on new drug pipeline

CEO John Lechleiter says Lilly’s pipeline has helped it rebound from significant patent losses three times during his 30-year
career at the company. He’s betting there will be a fourth.

Read More

Goodwill executive to lead national health care board

Goodwill Industries executive Keith Reissaus has been tapped to run Washington, D.C.-based Leapfrog Group, an industry coalition.
Reissaus gained control of health care costs by giving employees incentives to care about their health.

Read More

Drugs in our water

Researchers are finding a host of pharmaceutical residues in tributaries to the White River, from which Indianapolis and other
cities draw drinking water.

Read More

Democrats eye insurance industry’s antitrust protection

Top Senate Democrats intend to try to strip the health insurance industry of its exemption from federal antitrust laws, according
to congressional officials, the latest evidence of a deepening struggle over President Barack Obama’s effort to overhaul the
health care industry.

Read More

Lilly reports $942 million profit in third quarter

Excluding special items, Eli Lilly and Co.’s earnings per share spike 22 percent on the strength of Alimta, Cymbalta and Humalog
sales. Lilly’s revenue rose 7 percent in the quarter over the same period of 2008,
to $5.56 billion.

Read More